Dr. Reddy's Laboratories (NYSE:RDY) Lowered to "Buy" at Stoc

StockNews.com cut shares of Dr. Reddy’s Laboratories (NYSE:RDY – Free Report) from a strong-buy rating to a buy rating in a research note issued to investors on Saturday morning. Separately, Jefferies Financial Group lowered shares of Dr. Reddy’s Laboratories from a buy rating to an underperform rating in a research note on Thursday, January 11th. […]

Related Keywords

, Ronald Blue Trust Inc , Jefferies Financial Group , Reddy Laboratories , Wealth Advisors , Harbour Investments Inc , Free Report , Laboratories Trading Down , Jacobson Investment Advisors , Ronald Blue Trust , Blue Trust , Get Free Report , Laboratories Limited , Global Generics , Pharmaceutical Services , Active Ingredients , Laboratories Daily , Dr Reddys Laboratories , Nyse Rdy , Ardy , Medical , Downgrade , Stocknews Com ,